Apollo Hospitals Enterprise Limited (APOLLOHOSP) — Financial Results | 30 May 2025(3 announcements)

· NSE 🔴 High Importance Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
1 Financial Results 🔴 High Importance Neutral 📄 PDF

Apollo Hospitals reported consolidated PAT of Rs 1,446 crores for FY25, a 61% YoY increase, with revenue reaching Rs 21,794 crores (+14% YoY). Q4 PAT rose 54% to Rs 390 crores, and EBITDA grew 20% to Rs 770 crores. The company announced plans to add over 4,300 beds across India by FY26 with a capital investment of Rs 8,000 crores, primarily funded through internal accruals. Key growth drivers include healthcare services revenue of Rs 10,000 crores and strategic expansions in major cities.

2 Financial Results 🔴 High Importance Neutral 📄 PDF

Apollo Hospitals reported consolidated PAT of Rs 1,446 crores for FY25, a 61% YoY increase, with revenue reaching Rs 21,794 crores (+14% YoY). Q4 PAT rose 54% to Rs 390 crores, and EBITDA grew 20% to Rs 770 crores. The company announced plans to invest over Rs 8,000 crores in expanding capacity by 4,300 beds across new facilities in multiple cities by FY26, including a 500-bed greenfield hospital in Bengaluru. An unmodified audit confirmed financial stability, and the expansion targets high-growth urban healthcare markets.

3 Financial Results 🔴 High Importance Neutral 📄 PDF

Apollo Hospitals reported consolidated PAT of Rs 1,446 crores for FY25, a 61% YoY increase, with revenue reaching Rs 21,794 crores (+14% YoY). Q4 PAT rose 54% to Rs 390 crores, and EBITDA grew 20% to Rs 770 crores. The company announced plans to add over 4,300 beds across India by FY26, investing over Rs 8,000 crores in new facilities including greenfield hospitals in Sarjapur, Bengaluru, and expansions in Varanasi, Mumbai, and Lucknow. The unmodified audit confirms financial stability, while expansion targets 1,500 beds in Bengaluru and 8,000 system-wide.

About Apollo Hospitals Enterprise Limited (APOLLOHOSP)

Healthcare · Healthcare Services · Listed on NSE

Market Cap: ₹1,16,213.95 Cr P/E: 64.5 ROE: 21.9% ROCE: 20.5%

View full APOLLOHOSP stock details →

📡 Get AI alerts when APOLLOHOSP files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track APOLLOHOSP — Free

📊 More APOLLOHOSP filings

See all APOLLOHOSP filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when APOLLOHOSP files new disclosures

Track APOLLOHOSP filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track APOLLOHOSP — Free

Free account · 2 AI queries/day